Voltage-gated potassium channel subfamily A (Kv1) (Kv1)

The Shaker-type voltage-gated potassium channel, primarily represented by the Kv1 (KCNA) subfamily, is a critical regulator of cellular excitability and ion homeostasis [1, 15]. These channels are composed of four alpha-subunits that form a selective pore for potassium ions, opening in response to membrane depolarization to facilitate repolarization of the action potential [13, 17]. In the nervous system, members like Kv1.1 and Kv1.2 are essential for controlling the timing and frequency of neuronal firing, while Kv1.3 plays a specialized role in the activation and proliferation of effector memory T cells [3, 22]. Mutations in the KCNA1 gene are linked to neurological disorders such as episodic ataxia type 1 and epilepsy, whereas overactivity or aberrant expression of other family members is associated with autoimmune diseases and certain cancers [6, 19]. Pharmacological modulation of these channels includes the use of small-molecule blockers like 4-aminopyridine for multiple sclerosis and peptide toxins like dalazatide for autoimmune conditions [1, 21]. Therapeutic development focuses on achieving subtype selectivity to avoid off-target effects, such as cardiac arrhythmias or central nervous system toxicity, which remain significant challenges in the field [20, 22].

Other names

Shaker-related potassium channelKCNA familyShaker-type potassium channelVoltage-gated potassium channel subfamily AKv1 family

Drugs targeting Shaker-type channels typically act as pore blockers that physically occlude the ion conduction pathway, or as gating modifiers that interact with the voltage-sensor domain to alter the channel's response to membrane potential changes [1, 22].